Business Description
Awakn Life Sciences Corp
NAICS : 541714
SIC : 3741
ISIN : CA05455W1086
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | -2.28 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -81.91 | |||||
Beneish M-Score | -47.23 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -44.9 | |||||
3-Year EPS without NRI Growth Rate | -73.6 | |||||
3-Year FCF Growth Rate | -26 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 27.42 | |||||
9-Day RSI | 36.87 | |||||
14-Day RSI | 41.7 | |||||
6-1 Month Momentum % | 14.29 | |||||
12-1 Month Momentum % | -7.69 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.29 | |||||
Quick Ratio | 0.29 | |||||
Cash Ratio | 0.23 | |||||
Days Sales Outstanding | 362.48 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -16.9 | |||||
Shareholder Yield % | -28.95 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -4172.41 | |||||
Net Margin % | -4134.48 | |||||
FCF Margin % | 5203.45 | |||||
ROA % | -350.69 | |||||
ROIC % | -1852.99 | |||||
ROC (Joel Greenblatt) % | -242000 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 47.5 | |||||
Price-to-Free-Cash-Flow | 0.95 | |||||
Price-to-Operating-Cash-Flow | 0.95 | |||||
EV-to-EBIT | -1.47 | |||||
EV-to-EBITDA | -1.48 | |||||
EV-to-Forward-EBITDA | -0.52 | |||||
EV-to-Revenue | 61.22 | |||||
EV-to-Forward-Revenue | 2.2 | |||||
EV-to-FCF | 1.18 | |||||
Earnings Yield (Greenblatt) % | -68.03 | |||||
FCF Yield % | 76.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Awakn Life Sciences Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.058 | ||
EPS (TTM) (C$) | -0.07 | ||
Beta | 2.55 | ||
Volatility % | 126.6 | ||
14-Day RSI | 41.7 | ||
14-Day ATR (C$) | 0.006734 | ||
20-Day SMA (C$) | 0.10225 | ||
12-1 Month Momentum % | -7.69 | ||
52-Week Range (C$) | 0.06 - 0.23 | ||
Shares Outstanding (Mil) | 41.66 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Awakn Life Sciences Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Awakn Life Sciences Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Awakn Life Sciences Corp Frequently Asked Questions
What is Awakn Life Sciences Corp(XCNQ:AWKN)'s stock price today?
When is next earnings date of Awakn Life Sciences Corp(XCNQ:AWKN)?
Does Awakn Life Sciences Corp(XCNQ:AWKN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |